Visualizing breast lesions with the second generation Twente photoacoustic mammoscope (PAM 2)

Prof. dr. ir. Wiendelt Steenbergenon behalf of:Biomedical Photonic ImagingMIRA InstituteUniversity of Twente0 个研究点目标入组 130 人开始时间: 待定最近更新: 2024年2月28日

试验速览

n/a

•Adult women who come to the mammapoli with a lesion suspicious for malignancy, which, after clinical investigation and diagnostic imaging is classified as BIRADS 4 or 5, or BIRADS 2 or 3;
•- Subjects who are fully competent to give informed consent.
•For healthy volunteer measurements:
•- Adult women;
•- Subjects who are fully competent to give informed consent.

•- Subjects who have a cup size of D or larger OR subjects for whom the biggest size breast supporting cup is too small;
•- Subjects who had a breast biopsy in the 6 months prior to this study;
•- Subjects with bloody discharge, ulcers or wounds on the breast;
•- Subjects with a history of surgery (including cosmetic surgery) or radiation
•therapy on the breast;
•- Subjects who are currently undergoing chemotherapy.
•For healthy volunteer measurements:
•- Subjects who have a cup size of D or larger OR subjects for whom the biggest size breast supporting cup is too small;
•- Subjects who have symptoms of breast cancer such as a palpable mass which
•might be attributed to breast cancer;
•- Subjects who have had (a) benign breast lesion(s) in the past;
•- Subjects who have had breast cancer in the past;
•- Subjects who had a breast biopsy in the 6 months prior to this study;
•- Subjects with blood discharge, ulcers or wounds on the breast;
•- Subjects with a history of surgery (including cosmetic surgery) or radiation
•therapy on the breast;
•- Subjects who are currently undergoing chemotherapy.

发起方

Prof. dr. ir. Wiendelt Steenbergenon behalf of:Biomedical Photonic ImagingMIRA InstituteUniversity of Twente